Skip to content

Clinical Performance Testing Using the Fully Automated Genetic Testing Device GENECUBE and Respiratory Pathogen Genetic Detection Reagents in Respiratory Specimens

Clinical Performance Testing Using the Fully Automated Genetic Testing Device GENECUBE and Respiratory Pathogen Genetic Detection Reagents in Respiratory Specimens

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030260181
Enrollment
1000
Registered
2026-06-02
Start date
2026-06-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious diseases Infectious diseases

Interventions

None listed

Sponsors

Suzuki Hiromichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients presenting with suspected respiratory infection who have new consented specimens or residual/stored specimens such as postnasal, nasopharyngeal, pharyngeal swabs, or sputum.

Exclusion criteria

Exclusion criteria: When consent is withdrawn When a request to refuse secondary use is made for stored specimens originating from other studies When no residual specimens remain

Design outcomes

Primary

MeasureTime frame
Comparative performance evaluation of GENECUBE versus existing methods (e.g., LAMP) for M. pneumoniae detection in nasopharyngeal swabs.

Secondary

MeasureTime frame
Detection of M. pneumoniae variants and drug susceptibility; evaluation of B. pertussis, C. pneumoniae, C. psittaci, Legionella, Rickettsia, Coxiella; pretreatment, composition, device settings; sensitivity, reproducibility, stability; cross-reactivity; magLEAD optimization; simultaneous detection of respiratory pathogens and resistance genes.

Contacts

Public ContactAsako kaizu

University of Tsukuba Hospital

tsukuba-idcenter@gwe.md.tsukuba.ac.jp+81-29-853-3682

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026